Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Neurogene Inc. (NGNE) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Neurogene Inc. (NGNE), most recent 12 months reported: revenue $0, net loss $111.11M, free cash flow -$87.71M. Latest balance sheet on file: liquid cash $225.39M. From SEC filings. Others in Pharmaceutical Preparations: METAVIA INC. · NovaBridge Biosciences · NewcelX Ltd. · Minerva Neurosciences, Inc. · NIKA PHARMACEUTICALS, INC. · Nkarta, Inc. · NOMAD POWER SOLUTIONS, INC. · NANOVIRICIDES, INC.

Stock screener

Watchlist